Venous insufficiency of the corpora cavernosa is the second most common cause of erectile dysfunction (ED). A functional insufficiency of the venous system has been hypothesised, but the cause is still unclear. To evaluate a possible endocrine mechanism, we have studied hormone profile in a group of nine patients with pure venous-leakage (VL) compared with a control group of 15 patients with ED of different origin. Prolactin, testosterone and gonadotropin levels did not differ among the two groups, while estradiol (E2) plasma concentration was significantly higher in VL patients compared to controls. Our data support the hypothesis that the steroid environment, in particular estradiol level, can influence venous vascular tone (via VEGF or NO), thus affecting venous leakage dysfunction. This point can explain a possible link between the high estradiol levels and a functional insufficiency of the venous system in ED.
Introduction
Erectile function is a hemodynamic process of blood inflow and pressure maintenance in the cavernosal spaces. During erection, blood filling of sinusoidal spaces compresses subtunical venules, thereby reducing venous outflow. Corporeal veno-occlusive (CVO) incompetence may be regarded as impotence resulting from excessive venous outflow from corporum cavernosum. A venous leakage can be due to damaged venous valves or to abnormal arterovenous connection. Venous insufficiency of the corpora cavernosa is the second most common cause of erectile dysfunction (ED).
Different anatomic conditions, such as atrophy, fibrosis, Peyronie's disease or arteriogenic (AR) lesions can be the underlying causes. A functional insufficiency of the venous system has also been hypothesised, but the cause is still unclear.
The role of androgens in the maintenance of the processes of penile erection is less clear. Much research indicates that nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) are major neurotransmitters mediating the relaxation of the corpora cavernosa, but it is not entirely known whether steroid hormones regulate this action on vascular tone. 1 Furthermore, it was reported that vascular endothelial growth factor (VEGF) improves erectile function and its expression was modulated by testosterone. 2 In order to evaluate a possible endocrine mechanism contributing to this phenomenon, we have studied plasma sex hormone profile in a group of patients with pure venous-leakage (VL) compared with a control group with ED of different origin (CTR).
Materials and methods
Male outpatients with ED of unknown origin of at least 6 months duration studied in the last few years, who met strict inclusion criteria, were considered for analysis: that is, age o65 y, body mass index (BMI) o27 kg/m 2 , absence of diabetes mellitus or other endocrine disorders including abnormal libido, major psychiatric disorders, liver or kidney dysfunction, recent acute myocardial infarction, Peyronie's disease, no drug consumption during the month prior to the study as well as no smoking history.
Nine patients aged 25-50 y with VL, diagnosed by color-coded duplex sonography after intracavernous prostaglandin injection (alprostadil, 10 mg), and 15 controls aged 30-52 y, with psychogenic and/or mixed organogenic-psychogenic abnormalities, excluding major vascular damage, were studied.
Evaluation of the cavernous arteries' flow was performed with a dedicated machine (Esaote Biomedica, Genova, Italy) using color-power Doppler software.
Flow parameters included peak systolic velocities (PSVs), end diastolic velocities (EDVs) and the resistive index (RI) after a standardized pharmacostimulation with 10 mg PGE1. Redosing of 10 mg PGE1 was performed when necessary in order to maximize the erectile response and to give better diagnostic sensitivity. AR and CVO dysfunction were defined by the presence of an altered inflow in the cavernous arteries (PSV o30 cm/s) or normal inflow but persistent high diastolic flow (EDV45 cm/s and RIo0.90) determined by Duplex ultrasound after 20 min from pharmacostimulation, respectively. The diagnosis of psychogenic impotence was based on comprehensive psychogenic testing and sexual questionnaires, and confirmed by normal Duplex ultrasound, that is, normal cavernous arteries inflow (PSV430 cm/s) and RI values (40.90).
All subjects also had routine hormonal (LH, total and free testosterone, estradiol, prolactin, SHBG) and biochemical (serum glucose, glycosylated hemoglobin, cholesterol, creatinine, AST, ALT) evaluation between 0800 and 0900 h before penile blood flow studies.
Fasting basal blood samples plasma were collected at 0800 and FT3, FT4, FSH, LH, prolactin (PRL), testosterone (T) and estradiol (E2) concentrations were determined by RIA (Chematil, Milan, Italy). TSH was determined by the IRMA method (Radim, Pomezia-Rome, Italy, standard MRC 80/ 558). Validity of the assays was double-checked by conventional tests of parallelism and recovery. Reference values established in our laboratory for a group of apparently healthy subjects. Normal range was: FSH from 2.5 to 15 UI/l; LH from 2.5 to 15 UI/l; PRL from 5 to 20 ng/ml; T from 3.5 to 8.0 ng/ml; FT3 from 2.3 to 4.2 pg/ml; FT4 from 5.5 to 14.5 pg/ml; and TSH from 0.5 to 2.8 mU/l. E2 was measured directly in plasma by a liquid phase technique using a 125 I-tracer and a second antibody to separate the free from the antibodybound fraction. Normal range was from 20 to 40 pg/ ml.
Intra-and interassay coefficients of variation were: FSH, 6.9 and 8.4%; LH, 5.6 and 9.1%; PRL, 2.1 and 3.1%; T, 6.1 and 9.3%; E2, 2.3 and 3.5%, FT3, FT4, TSH, 4.2 and 5.2% respectively.
Statistical analysis
The distribution of the data was evaluated by the Kolmogorov-Smirnov test. As the data were not normally distributed, the comparison among groups was performed using the Mann-Whitney test.
Software Arcus Quickstat (Software Publishing, Biomedical Version 1.2) was used for these statistical analyses.
Results
All the patients had normal echogenicity of the penile structures, with no features of intracorporal fibrosis. None of these men were cigarettes smoking.
The variables assessed are shown in Table 1 . Patients with veno-occlusive dysfunction exhibited a poor response to intracavernous injection, despite good arterial flow demonstrated by duplex ultrasound. Penile engorgement and elongation with no rigidity occurred in five patients. There was no erection in the four remaining men.
PRL, TSH, FT3, FT4, testosterone and gonadotropin levels did not differ among the two groups while estradiol plasma concentration was significantly higher in VL patients compared to controls (mean7s.e.m. 49.876.6 vs 33.3874.3 pg/ml, respectively) (Figure 1 ,*Po0.05 vs CTR). It has been demonstrated that androgens mediate the erectile response in the rat penis by stimulating the expression of the neuronal isoform of NO synthase, thus maintaining an adequate supply of NO. 5 Therefore, in animal models it has been shown that T, besides its central action, may regulate erectile function locally via actions on the NOguanylate cyclase-cGMP pathway. 6 In the penis, T actions are mainly exerted via a specific interaction with the androgen receptor present in the smooth muscle cells. 7 As such, the penis is a predominantly vascular organ, and vascular insufficiency is the most common etiology of ED. Sinusoidal smooth muscle atrophy and collagen deposition are commonly found in men with long-standing ED of various etiologies, whether hormonal, neurological or vascular. Such degradation in smooth muscle quantity and quality leads to veno-occlusive dysfunction. The mechanism of this phenomenon is not still clear.
Cavernosometry and cavernosography is traditionally the gold standard for evaluation of venogenic impotence. However, these procedures are invasive, uncomfortable and there are potentially significant complications. It also has many inherent variables, such as type and dosage of the vasoactive agent, timing, maintenance rate vs pressure decay rate, and mode of infusion (pump vs gravity). 8 Penile color flow Doppler imaging is noninvasive and can be used to assess venous incompetence. The role of ultrasound in the evaluation of venoocclusive failure is still controversial. More studies in the last decade supported that color Doppler sonography had a greater sensitivity, specificity, accuracy rate and a positive predictive value. [9] [10] [11] Other studies reported a significant sensitivity of this procedures, but a low specificity, and they recommend cavernosometry only in patients with an inadequate response to a diagnostic intracorporeal test injection. 12, 13 Moreover, cavernosometry should only be carried out in cases when color Doppler suggests venogenic impotence and when surgery is contemplated.
We evaluated the possible relationship between circulating hormones and haemodynamic parameters after pharmacoerection test in a group of men with ED of various aetiologies.
In the group of venogenic ED, the estrogen levels were significantly higher than controls. This phenomenon was probably due to bioconversion of androgens by the aromatizing enzyme in gonadal as well as peripheral tissues, since other major causes of hyperestrogenism, like hyperthyroidism, obesity, liver disease, testicular neoplasies were excluded.
It has been demonstrated that estrogens may influence vascular reactivity 14 in men and increase NO production by eNOS, due to increased eNOS expression and level of activation, via both genomic and nongenomic mechanism. 15 However, they are not strictly necessary for a normal sexual behavior in men, since data obtained from men with congenital estrogen deficiency showed unaffected sexual orientation and gender-identity; therefore, in these subjects no remarkable sexual disorder (libido, morning erections, ejaculation) was recorded. [16] [17] [18] On the other hand, estrogens increase SHBG, thus lowering free testosterone levels, which have been shown to be different when comparing psychogenic and organic ED. 19 Also in the study of Aversa et al, 20 estrogen plasma levels showed a trend to the higher in CVO ED vs other forms of ED, although not significantly. So, estrogen could positively influence NO production and therefore erectile function, but this effect could be counterbalanced by lowering of free-testosterone levels. Alternatively, estrogen could influence other factors, more recently investigated, with potential key role in erectile function.
A factor involved in this dysfunction may be VEGF, because of its known angiogenic effects and possible role as an androgen mediator. VEGF is a polypeptide secreted by a large number of cells that is mitogenic for endothelial cells and induces angiogenesis and vasculogenesis in vivo. It is also a potent stimulator of microvascular permeability and a chemotactic factor for endothelial cells and monocytes. VEGF has been shown to increase vascular permeability of postcapillary venules by inducing fenestration of the endothelium. 21 These effects of VEGF could be mediated, at least partly, by the production of NO by endothelial cells. A recent study in animals documented that treatment with intracavernous VEGF was able to reverse venogenic ED produced by castration. Moreover, different studies indicate that VEGF is under hormone controls. 22 Estradiol (E2) induces VEGF expression in human venous muscle cells and modulates VEGF effects in angiogenesis, vascular permeability and integrity. E2-induced VEGF expression in human veins could be mediated by the ER-b receptor. However, the mechanisms by which E2 influence VEGF expression in media (SMC) of veins is not entirely clear.
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Whether the physiological role of E2 is similar in veins and arteries remains unknown. It has been reported E2 accelerates functional endothelial recovery after arterial injury via an increase in NO and VEGF expression. 23 Whether VEGF could participate in the protective effect of E2 against the development of cardiovascular disease, in addition to vasorelaxation, preservation of the endothelium, inhibition of SMC proliferation, and antiatherogenic effects, is still unknown .
Our preliminary data support the hypothesis that the steroid environment, in particular estradiol level, can influence venous vascular tone (via VEGF or NO) thus affecting venous leakage dysfunction. This point can explain a possible link between the high estradiol levels and a functional insufficiency of the venous system in ED and underlies the importance of sex hormone determination in supporting potential therapeutic options.
